Factors for Treatment Failure After Fecal Microbiota Transplantation in Clostridioides difficile Infection

Area of Science:

• Gastroenterology
• Infectious Diseases
• Microbiology

Background:

• Fecal microbiota transplantation (FMT) is a promising treatment for Clostridioides difficile infection (CDI).
• Risk factors for FMT failure in CDI patients remain incompletely understood.
• Identifying these factors is crucial for optimizing treatment efficacy.

Purpose of the Study:

• To investigate risk factors associated with treatment failure or recurrence after FMT for CDI.
• To assess the impact of comorbidities, pre- and post-FMT antibiotic use, and prior CDI episodes on FMT outcomes.

Main Methods:

• Retrospective study of 124 CDI patients undergoing FMT.
• Follow-up for 8 weeks post-FMT, defining failure as diarrhea recurrence or positive stool test.
• Multivariate analysis to identify significant risk factors.

Main Results:

• Overall treatment failure rate was 32.3% (40/124 patients).
• Male patients showed a lower rate of symptom improvement within 7 days post-FMT (p=0.049).
• Antibiotic use after FMT was significantly associated with higher recurrence or treatment failure rates within 8 weeks (p=0.032).

Conclusions:

• Patients requiring antibiotics post-FMT are at higher risk of treatment failure.
• Minimizing non-essential antibiotic use before and after FMT is recommended.
• Further prospective studies are needed to confirm findings and develop targeted antibiotic management strategies.